🚀 VC round data is live in beta, check it out!

Jin Medical International Valuation Multiples

Discover revenue and EBITDA valuation multiples for Jin Medical International and similar public comparables like Prolight Diagnostics, Farmaceutica Remedia, Nortech Systems, iZafe Group and more.

Jin Medical International Overview

About Jin Medical International

Jin Medical International Ltd, along with its subsidiaries, mainly offers rehabilitation equipment. It is engaged in the design, development, manufacturing, and sales of wheelchairs and other assistive living aid products for use by people with disabilities or impaired mobility. The group's product offering includes wheelchairs and wheelchair components, oxygen concentrators, bathing machines, respiratory and walking aids, oxygen chambers, beauty instruments, and nano products, among others. Wheelchairs are currently its key revenue-generating product. The products are sold to dealers in Japan and China, and to some extent to dealers located in the United States, Canada, Australia, Korea, Israel, Singapore, and other regions. Geographically, the group generates maximum revenue from Japan.


Founded

2020

HQ

Japan

Employees

295

Financials (FY)

Revenue: $21M
EBITDA: $959K

EV

$12M

Valuation Multiples

Multiples.vc

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Jin Medical International Financials

Jin Medical International reported last fiscal year revenue of $21M and EBITDA of $959K.

In the same fiscal year, Jin Medical International generated $6M in gross profit, $959K in EBITDA, and $1M in net income.


Jin Medical International P&L

In the most recent fiscal year, Jin Medical International reported revenue of $21M and EBITDA of $959K.

Jin Medical International expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Jin Medical International forward-looking valuation multiples
LTMNTMLast FYFY 2026FY 2027FY 2028
RevenueXXX$21MXXXXXXXXX
Gross ProfitXXX$6MXXXXXXXXX
Gross MarginXXX29%XXXXXXXXX
EBITDAXXX$959KXXXXXXXXX
EBITDA MarginXXX5%XXXXXXXXX
EBIT MarginXXX3%XXXXXXXXX
Net ProfitXXX$1MXXXXXXXXX
Net MarginXXX6%XXXXXXXXX
Net Debt$11MXXXXXXXXX

Financial data powered by Morningstar, Inc.

Jin Medical International Stock Performance

Jin Medical International has current market cap of $23M, and enterprise value of $12M.

Market Cap Evolution


Jin Medical International's stock price is $0.14.

See Jin Medical International trading valuation data
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$12M$23M0.0%XXXXXXXXX$0.01

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Jin Medical International Valuation Multiples

Jin Medical International trades at 0.6x EV/Revenue multiple, and 12.5x EV/EBITDA.

See valuation multiples for Jin Medical International and 15K+ public comps

Jin Medical International Financial Valuation Multiples

As of March 28, 2026, Jin Medical International has market cap of $23M and EV of $12M.

Equity research analysts estimate Jin Medical International's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Jin Medical International has a P/E ratio of 19.0x.

LTMNTMLast FYFY 2026FY 2027FY 2028
Market cap (current)$23MXXX$23MXXXXXXXXX
EV (current)$12MXXX$12MXXXXXXXXX
EV/RevenueXXX0.6xXXXXXXXXX
EV/EBITDAXXX12.5xXXXXXXXXX
EV/EBITXXX19.6xXXXXXXXXX
EV/Gross ProfitXXX2.0xXXXXXXXXX
P/EXXX19.0xXXXXXXXXX
EV/FCFXXX(3.2x)XXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Jin Medical International Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Jin Medical International Margins & Growth Rates

Jin Medical International's revenue in the last fiscal year declined by (9%).

See operational valuation multiples for Jin Medical International and other 15K+ public comps

Jin Medical International Operational Valuation Multiples

LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue GrowthXXX(9%)XXXXXXXXX
EBITDA MarginXXX5%XXXXXXXXX
EBITDA GrowthXXX(70%)XXXXXXXXX
S&M Expenses to RevenueXXX7%XXXXXXXXX
G&A Expenses to RevenueXXX12%XXXXXXXXX
R&D Expenses to RevenueXXX8%XXXXXXXXX
Opex to RevenueXXX26%XXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Jin Medical International Public Comps

See public comps and valuation multiples for other Medical Supplies comps.

EV/RevenueEV/EBITDA
LTM2026E2027ELTM2026E2027E
Prolight DiagnosticsXXXXXXXXXXXXXXXXXX
Farmaceutica RemediaXXXXXXXXXXXXXXXXXX
Nortech SystemsXXXXXXXXXXXXXXXXXX
iZafe GroupXXXXXXXXXXXXXXXXXX
Balsm AlofoqXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX

Valuation data powered by FactSet, Inc.

Jin Medical International M&A Activity

Jin Medical International acquired XXX companies to date.

Last acquisition by Jin Medical International was on XXXXXXXX, XXXXX. Jin Medical International acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See M&A valuation multiples

Latest Acquisitions by Jin Medical International

Acquired CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.

Start Free Trial

Jin Medical International Investment Activity

Jin Medical International invested in XXX companies to date.

Jin Medical International made its latest investment on XXXXXXXX, XXXXX. Jin Medical International invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See VC round multiples

Latest Investments by Jin Medical International

CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Jin Medical International

When was Jin Medical International founded?Jin Medical International was founded in 2020.
Where is Jin Medical International headquartered?Jin Medical International is headquartered in Japan.
How many employees does Jin Medical International have?As of today, Jin Medical International has over 295 employees.
Who is the CEO of Jin Medical International?Jin Medical International's CEO is Erqi Wang.
Is Jin Medical International publicly listed?Yes, Jin Medical International is a public company listed on Nasdaq.
What is the stock symbol of Jin Medical International?Jin Medical International trades under ZJYL ticker.
When did Jin Medical International go public?Jin Medical International went public in 2023.
Who are competitors of Jin Medical International?Jin Medical International main competitors are Prolight Diagnostics, Farmaceutica Remedia, Nortech Systems, iZafe Group.
What is the current market cap of Jin Medical International?Jin Medical International's current market cap is $23M.
What is the current revenue of Jin Medical International?Jin Medical International's last fiscal year revenue is $21M.
What is the current EV/Revenue multiple of Jin Medical International?Current revenue multiple of Jin Medical International is 0.6x.
Is Jin Medical International profitable?No, Jin Medical International is not profitable.

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial